The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
Open Access
- 12 July 2020
- journal article
- editorial
- Published by Wiley in Microbiologyopen
- Vol. 9 (8) , e1061
Abstract
Clostridioides difficile infection (CDI) represents an important health problem worldwide, with significant morbidity and mortality. This infection has also high recurrence rates, whose pathophysiological grounds are still poorly understood. Based on our experiments in vitro with Clostridioides difficile toxin B and existing experimental and clinical evidence, we propose that primary CDI and relapses might be favored by a mechanism that involves the enhancement of the toxicity of toxin B by proinflammatory cytokines, tumor necrosis factor alpha, and interferon gamma on the enteric glial cells and their network in an environment characterized by a strong dysmicrobism.Keywords
This publication has 42 references indexed in Scilit:
- The Role of Cellular Senescence in the Gastrointestinal MucosaGut and Liver, 2013
- Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile InfectionClinical Infectious Diseases, 2013
- The dynamics of gut‐associated microbial communities during inflammationEMBO Reports, 2013
- Emergence and global spread of epidemic healthcare-associated Clostridium difficileNature Genetics, 2012
- Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidenceInternational Journal of Antimicrobial Agents, 2012
- The Enterotoxicity of Clostridium difficile ToxinsToxins, 2010
- Host immune response to antibiotic perturbation of the microbiotaMucosal Immunology, 2010
- Enteric glial cells: new players in gastrointestinal motility?Laboratory Investigation, 2007
- Differential Effects of Varying Concentrations ofClostridium difficileToxin A on Epithelial Barrier Function and Expression of CytokinesThe Journal of Infectious Diseases, 2004
- Clinical relevance of antibiotic-induced endotoxin releaseAntimicrobial Agents and Chemotherapy, 1994